METHOD FOR PREDICTION OF MODERATELY DIFFERENTIATED ENDOMETRIOID UTERINE BODY T1N0M0 CARCINOMA COURSE IN CASE OF PRIMARY TUMOUR SIZE WITHIN 1 cm

FIELD: medicine. SUBSTANCE: in case of primary tumour size within 1 cm, uterus tumour cells expressing Ki-67, 2 alpha topoisomerase are determined, 2 alpha topoisomerase/Ki-67 correlation coefficient is calculated, and at coefficient value less than or equal to 0.8, favorable outcome without adjuvant therapy is predicted. At coefficient value of more than 0.8, unfavorable course of the disease is predicted, and adjuvant therapy is recommended. EFFECT: use of the invention allows to improve the accuracy and information content of moderately differentiated endometrioid uterine carcinomas course prediction. 1 tbl, 2 ex